Back to Search
ALAN WEISSER, PH.D.
PH.D.
Clinical Psychologist
NPI: 1225184666IndividualAccepts Medicare
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
PY00001978(WA)
CMS Specialties
PrimaryCLINICAL PSYCHOLOGIST
Education
OTHER
Class of 1993
Research & Publications (14)
Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis.
PMID 16617318·Leukemia·2006
4-observational
Treatment concepts of acute promyelocytic leukemia.
PMID 16236522·Crit Rev Oncol Hematol·2005
6-review
The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.
PMID 15800673·Leukemia·2005
5-case
Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer.
PMID 15138468·Br J Cancer·2004
3-trial
Monitoring of minimal residual disease in acute promyelocytic leukemia.
PMID 15124684·Ann Hematol·2004
8-other
Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
PMID 12970765·Leukemia·2003
4-observational
Treatment of a patient with advanced esophageal cancer with a combination of mitomycin C and capecitabine: activation of the thymidine phosphorylase as active principle?
PMID 12771525·Onkologie·2003
5-case
Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia.
PMID 12508246·Genes Chromosomes Cancer·2003
4-observational
Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization.
PMID 12454744·Leukemia·2002
4-observational
Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
PMID 12200666·Leukemia·2002
3-trial
Overexpression of SOCS-2 in advanced stages of chronic myeloid leukemia: possible inadequacy of a negative feedback mechanism.
PMID 11861294·Blood·2002
8-other
Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes.
PMID 11069038·Leukemia·2000
4-observational
Detection and quantification of residual disease in chronic myelogenous leukemia.
PMID 10865964·Leukemia·2000
6-review
Reduced (1)H-NMR visibility of creatine in isolated rat hearts.
PMID 10748423·Magn Reson Med·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7120 WOODLAWN AVE NE
SEATTLE, WA 98115 - Phone
- (206) 323-9199
Quick Facts
- NPI
- 1225184666
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 14
Are you this provider?
Claim Your Profile